Diabetes mellitus and degos disease

Bratislava Medical Journal

Volumn 109, Issue 9, 2008, Pages 414-417

  Fernandez Flores, A ^a,c   Manjon, J A ^a   Mencia, J ^b  

^a HOSPITAL EL BIERZO   (Spain)

^b Medicina Familiar y Comunitaria   (Spain)

^c Service of Cellular Pathology   (Spain)

Author keywords

C5b 9; Degos disease; Diabetes mellitus; Hyaline arteriolosclerosis; Hyaline vasculopathy

Indexed keywords

AGED; ARTICLE; CASE REPORT; HUMAN; MALE; MALIGNANT ATROPHIC PAPULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; SKIN;

AGED; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; MALIGNANT ATROPHIC PAPULOSIS; SKIN;

EID: 57049173046     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Black MM, Nishioka K, Levene GM. The role of dermal blood vessels in the pathogenesis of malignant atrophic papulosis (Degos' disease). Brit J Dermatol 1973; 88 (3): 213-219.
2. Páramo JA, Rocha E, Cuesta B, Arejola JM, Montejo M, Aguirre J, Prieto J, Rocha Hernando E. Fibrinolysis in Degos' disease. Thromb Haemost 1985; 54 (3): 730.
3. Vázquez-Doval FJ, Ruiz de Erenchun F, Paramo JA, Quintanilla E. Malignant atrophic papulosis. A report of two cases with altered fibrinolysis and platelet function. Clin Exp Dermatol 1993; 18 (5): 441-444.
4. Katz SK, Mudd LJ, Roenigk HH. Malignant atrophic papulosis (Degos' disease) involving three generations of a family. J Amer Acad Dermatol 1997; 37 (3 Pt 1): 480-484.
5. Naylor D, Mullins JF, Gilmore JF. Papulosis atrophicans maligna (Degos' disease): report of the first United States case and review of the literature. Arch Dermatol 1969; 81 (Feb): 189-197.
6. Su WPD, Schroeter AL, Lee DA, Hsu T, Muller SA. Clinical and histologic findings in Degos' syndrome (malignant atrophic papulosis). Cutis 1985; 35 (2): 131-138.
7. Soter NA, Murphy GF, Mihm MC Jr. Lymphocytes and necrosis of the cutaneous microvasculature in malignant atrophic papulosis: a refined light microscope study. J Amer Acad Dermatol 1982; 7 (5): 620-630.
8. High WA, Aranda J, Patel SB, Cockerell CJ, Costner MI. Is Degos disease a clinical and histological end point rather than a specific disease? J Amer Acad Dermatol 2004; 50 (6): 895-899.
9. Ball E, Newburger A, Ackerman AB. Degos' disease is a distinctive pattern, chiefly of lupus erythematosus, and not a specific disease. Dermatopath Pract Conc. 2001; 7. Available at: http//. Accessed October 17, 2007.
10. Farrell AM, Moss J, Costello C, Fearfield LA, Woodrow D, Bunker CB. Benign cutaneous Degos' disease. Brit J Dermatol 1998; 139 (4): 708-712.
11. Bogenrieder T, Kuske M, Landthaler M, Stolz W. Benign Degos' disease developing during pregnancy and followed for 10 years. Acta Derm Venereol 2002; 82 (4): 284-287.
12. Englert HJ, Hawkes CH, Boey ML, Derue GJ, Loizou S, Harris EN, Gharavi AE, Hull RG, Hughes GR. Degos' disease: association with anticardiolipin antibodies and the lupus anticoagulant. Brit Med J 1984; 289 (6445): 576.
13. Mauad T, De Fátima Lopes Calvo Tiberio I, Baba E, Andrade Junior DR, Lichtenstein A, Capelozzi VL, Sotto MN, Saldiva PH. Malignant atrophic papulosis (Degos' disease) with extensive cardiopulmonary involvement. Histopathology 1996; 28 (1): 84-86.
14. Zamiri M, Jarrett P, Snow J. Benign Cutaneous Degos disease. Int J Dermatol 2005; 44 (8): 654-656.
15. Coskun B, Saral Y, Cicek D, Ozercan R. Benign cutaneous Degos' disease: a case report and review of the literature. J Dermatol 2004; 31 (8): 666-670.
16. Requena L, Faria C, Barat A. Degos disease in a patient with acquired immunodeficiency syndrome. J Amer Acad Dermatol 1998; 38 (5 Pt 2): 852-856.
17. D'Avino M, Lo Schiavo A, Baroni A, Buommino E, Ruocco E. Degos' disease: a case with cutaneous lesions only: absence of paramyxovirus by PCR. Dermatol 2000; 201 (3): 278-279.
18. Grilli R, Soriano ML, Izquierdo MJ, Faria MC, Martin L, Manzarbeitia F, Requena L. Panniculitis mimicking lupus erythematosus profundus. Amer J Dermatopathol 1999; 21 (4): 365-368.
19. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (10): 295-306.
20. Lockshin MD. Update on antiphospholipid syndrome. Bull NYU Hosp Joint Dis 2006; 64 (1-2): 57-59.
21. Vasil KE, Magro CM. Cutaneous vascular deposition of C5b-9 and its role as a diagnostic adjunct in the setting of diabetes mellitus and porphyria cutanea tarda. J Amer Acad Dermatol 2007; 56 (1): 96-104.
22. Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 1996; 27: 15-19.
23. Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol 1997; 24 (9): 543-552.
24. Vilas AP, Fiuza T. Classic/amyopathic dermatomyositis. Acta Med Port 2000; 13 (5-6): 287-294.
25. Redecha P, Tilley R, Tencati M, Salmon JE, Kirchhofer D, Mackman N, Girardi G. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 2007; 110 (7): 2423-2431.
26. Stewart MW, Etches WS, Gordon PA. Antiphospholipid antibody-dependent C5b-9 formation. Brit J Haematol 1997; 96 (3): 451-457.
27. Romay-Penabad Z, Liu XX, Montiel-Manzano G, Papalardo De Martínez E, Pierangeli SS. C5a receptor-deficient mice are protected from thrombophilia and endotelial cell activation induced by some antiphospholipid antibodies. Ann N Y Acad Sci 2007; 1108 (June): 554-566.
28. Stevanovic DV. Atrophic blanche: a sign of dermal blood oclusion. Arch Dermatol 1974; 109 (6): 858-862.
29. Salomon MI, Mandel EH, Gallo G. Degos' disease associated with a "spontaneous cure" of diabetes. J Amer Geriatr Soc 1971; 19 (11): 923-932.
30. Manzanares JM, Conget I, Rodríguez-Villar C, Tassies D, Fernandez-Fernandez F, Cervera R, Levy I, Gomis R. Antiphospholipid syndrome in a patient with type I diabetes presenting as retinal artery occlusion. Diabet Care 1996; 19 (1): 92-94.
31. Li HY, Yang W-S, Tai T-Y, Chuang LM. A diabetic subject with MELAS and antiphospholipid syndrome. Diabet Care 2003; 26 (7): 2218-2219.
32. Kim CS, Kim DM, Park JS, Nam JY, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC. A case of primary antiphospholipid syndrome and type 2 diabetes mellitus with large artery thromboses successfully treated by abdominal stent implantation. Diabet Med 2004; 21 (11): 1258-1259.